Why is the nation's capital suddenly obsessed with biomedical innovation? And why is the fruit of that obsession, the 21st Century Cures Act, moving like a greased pig through the usually deadlocked Congress—even as some experts warn it could undermine the FDA's ability to protect the public from unproven and potentially unsafe new drugs and medical devices?